EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigallocatechin-3-Gallate Restores the Pulmonary Keap1-Nrf2-HO-1 Pathway and Attenuates Bile Acid-Associated Lung Injury in a Mouse Model of MASH

Ahmad Salhab iD, Johnny Amer, Rifaat Safadi

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27208948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ahmad Salhab und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Liver Institute, Gastroenterology Institute, Hadassah-Hebrew University Hospital, Jerusalem 91120, Israel. Hauptthemen laut MEDLINE: Catechin, Bile Acids and Salts, NF-E2-Related Factor 2, Lung Injury. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The crosstalk between the liver and the lung is complex and not yet fully understood; however, recent studies suggest that metabolic dysfunction, often originating in the liver, can influence lung injury and other lung diseases. The current study investigates the role of bile acids (BA) in mediating lung injury in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH). Ob/Ob mice were fed a high-fat diet (HFD) for 4 weeks to establish a MASH model. Littermate mice were used as controls. Mice of each genotype were randomized to epigallocatechin-3-gallate (EGCG; 200 mg/kg/day, oral gavage) or vehicle. BA levels were assessed in serum and bronchoalveolar lavage fluid (BALF), and lung and liver tissues were obtained and evaluated for histological damage, epithelial apoptosis, and oxidative stress markers. MASH mice exhibited significant pulmonary injury, characterized by elevated pulmonary Sftpd mRNA expression (2.10 ± 0.68-fold) and sRAGE levels (986 ± 144 pg/mL), together with increased apoptosis of alveolar type I (30.0 ± 8.0%) and type II (32.4 ± 7.8%) epithelial cells, indicating impaired alveolar integrity. Pulmonary oxidative stress was evidenced by increased malondialdehyde (MDA) levels (0.67 ± 0.11 nmol/mg tissue) and a marked reduction in superoxide dismutase (SOD) protein levels (6.25 ± 3.30 ng/mg tissue). Serum bile acid concentrations were significantly elevated (14.99 ± 2.80 µM; 11.9-fold increase), accompanied by a 5.6-fold increase in BALF BA concentrations. EGCG treatment reduced serum bile acid concentrations to 9.68 ± 2.18 µM and BALF bile acid levels to 0.274 ± 0.125 µM, while decreasing Sftpd expression (1.29 ± 0.25-fold), sRAGE (392 ± 234 pg/mL), alveolar epithelial apoptosis (AT-1: 15.0 ± 3.8%; AT-2: 22.1 ± 7.0%), and MDA levels (0.36 ± 0.10 nmol/mg tissue). In parallel, EGCG significantly restored pulmonary SOD protein levels (17.80 ± 5.91 ng/mg tissue). Mechanistically, EGCG restored the transcriptional expression of the pulmonary Keap1-Nrf2-HO-1 antioxidant pathway by suppressing Keap1 while increasing Nfe2l2 and Hmox1 expression, consistent with improved endogenous antioxidant defenses and redox homeostasis. In conclusion, MASH is accompanied by pulmonary injury, alveolar epithelial apoptosis and oxidative stress, occurring in parallel with systemic and alveolar bile acid accumulation. EGCG attenuated these changes and was associated with recovery of pulmonary Keap1-Nrf2-HO-1 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatechinBile Acids and SaltsNF-E2-Related Factor 2Lung InjurySignal TransductionKelch-Like ECH-Associated Protein 1Heme Oxygenase-1Fatty LiverAnimalsMiceDisease Models, AnimalMaleOxidative StressLungApoptosisMice, Inbred C57BLMembrane ProteinsLiver

Stichwörter der Autor:innen

EGCGMASHbile acidsliver–lung axislung injury

Substanzen

epigallocatechin gallateCatechinBile Acids and SaltsNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Heme Oxygenase-1Keap1 protein, mouseNfe2l2 protein, mouseMembrane Proteins

Autor:innen und Institutionen

  • The Liver Institute, Gastroenterology Institute, Hadassah-Hebrew University Hospital, Jerusalem 91120, Israel.

ORCID-Profile: Ahmad Salhab

Zitieren

APA

Salhab, A., Amer, J., & Safadi, R. (2026). Epigallocatechin-3-Gallate Restores the Pulmonary Keap1-Nrf2-HO-1 Pathway and Attenuates Bile Acid-Associated Lung Injury in a Mouse Model of MASH. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27208948

Vancouver

Salhab A, Amer J, Safadi R. Epigallocatechin-3-Gallate Restores the Pulmonary Keap1-Nrf2-HO-1 Pathway and Attenuates Bile Acid-Associated Lung Injury in a Mouse Model of MASH. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27208948

BibTeX
@article{Salhab2026,
  author = {Salhab, Ahmad and Amer, Johnny and Safadi, Rifaat},
  title = {Epigallocatechin-3-Gallate Restores the Pulmonary Keap1-Nrf2-HO-1 Pathway and Attenuates Bile Acid-Associated Lung Injury in a Mouse Model of MASH},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27208948}
}
Kostenlos starten →